Asseli Brahim, Djeridane Amar, Mahfoudi Reguia, Yousfi Mohamed
Laboratory of Fundamental Sciences, University Amar Telidji, PB 37 G, 03000 Laghouat, Algeria.
J Diabetes Metab Disord. 2021 Feb 13;20(1):427-438. doi: 10.1007/s40200-021-00762-x. eCollection 2021 Jun.
Several medicinal plants are used in the steep area of Algeria (Laghouat) for treatment of inflammation and diabetes. Furthermore, Botsch. (Chenopodiaceae) a xerophytic plant popularly known as (Ajram) is widely spread perennial shrub in Laghouat region and it is traditionally used to treat inflammation and diabete. Then, the objective of this work is to study for the first time the in vivo anti-inflammatory, antidiabetic and acute toxicity effects of acetonic, methanolic and aqueous Botsch extracts.
The acute toxicity test was performed according to the OECD method using single increasing doses (50-1500 mg/kg bw). The anti-inflammatory effect is investigated in Wistar rats by using the rat paw edema assay. The antidiabetic activity was evaluated in vivo using three tests: short-term test (in non-diabetic rats), starch-induced hyperglycemia test (in non-diabetic rats) and long-term alloxan test (experimental diabetes).
The acute toxicity results show no deaths in rats and no clinical signs of toxicity. The anti-inflammatory effects showed that all extracts significantly inhibit rat paw edema (EC less than 345.51 ± 0.29 mg/kg bw). Therefore, the acetonic extract (EC = 157.45 ± 0.33 mg/kg bw) had the more active anti-inflammatory activity than that of the standard inhibitor "Ibuprofen". In addition, the evaluation of the antidiabetic activities by three tests shows that: in, in the short-term test, there was no important decrease in normal rats glucose rate, while in the starch-induced hyperglycemia test, the aqueous extract decreased significantly hyperglycemia (57.21 ± 1.24 mg AEAC / kg bw) compared to all tested extracts. While in the long-term test, the acetone extract significantly decreased hyperglycemia (9.18 ± 0.72 mg GEAC / kg bw) compared to all the tested extracts.
Botsch extracts seem to have therapeutic opportunities for the treatment of the inflammation and diabetes.
在阿尔及利亚(拉格瓦特省)的干旱地区,有几种药用植物被用于治疗炎症和糖尿病。此外,藜科的旱生植物博奇(Botsch.),俗称“阿杰拉姆(Ajram)”,是拉格瓦特地区广泛分布的多年生灌木,传统上用于治疗炎症和糖尿病。因此,本研究的目的是首次研究博奇的丙酮提取物、甲醇提取物和水提取物的体内抗炎、抗糖尿病及急性毒性作用。
按照经合组织(OECD)的方法,使用单次递增剂量(50 - 1500毫克/千克体重)进行急性毒性试验。通过大鼠足爪肿胀试验在Wistar大鼠中研究抗炎作用。使用三项试验在体内评估抗糖尿病活性:短期试验(在非糖尿病大鼠中)、淀粉诱导的高血糖试验(在非糖尿病大鼠中)和长期四氧嘧啶试验(实验性糖尿病)。
急性毒性结果显示大鼠无死亡且无毒性临床症状。抗炎作用表明,所有提取物均能显著抑制大鼠足爪肿胀(半数有效浓度小于345.51±0.29毫克/千克体重)。因此,丙酮提取物(半数有效浓度 = 157.45±0.33毫克/千克体重)的抗炎活性比标准抑制剂“布洛芬”更强。此外,通过三项试验评估抗糖尿病活性表明:在短期试验中,正常大鼠的血糖水平没有显著下降,而在淀粉诱导的高血糖试验中,与所有测试提取物相比,水提取物显著降低了高血糖水平(57.21±1.24毫克无水乙醇提取物/千克体重)。而在长期试验中,与所有测试提取物相比,丙酮提取物显著降低了高血糖水平(9.18±0.72毫克葡萄糖当量提取物/千克体重)。
博奇提取物似乎具有治疗炎症和糖尿病的潜在机会。